Medovex Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 27
Employees
  • Stock Symbol
  • HCYT
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.05
  • (As of Friday Closing)

Medovex General Information

Description

H-CYTE Inc engages in the design and marketing of proprietary medical devices. It operates its business under two brands including Lung Health Institute, and DenerveX System. Lung Health Institute is a provider of regenerative medicine and provides an approach to addressing chronic lung disease. The DenerveX system is designed to treat facet joints. It uses Rotacapsulation to deliver high heat and capsular tissue shaving in a posterior capsulectomy procedure that treats the posterior synovial capsule, targets the facet joint nerve receptors, and terminates the nerve.

Contact Information

Website
www.hcyte.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Stock Exchange
PINX
Primary Office
  • 3060 Royal Boulevard South
  • Suite 150
  • Alpharetta, GA 30022
  • United States
+1 (404) 000-0000

Medovex Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medovex Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.05 $6.47M 124M 108K -$0.26

Medovex Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 10,526 15,160 10,123 10,113
Revenue 3,535 8,347 818 207
EBITDA (21,320) (28,674) (4,723) (6,033)
Net Income (23,091) (29,808) (4,909) (6,456)
Total Assets 4,108 3,271 404 1,228
Total Debt 1,267 2,894 697 171
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medovex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medovex‘s full profile, request access.

Request a free trial

Medovex Executive Team (8)

Name Title Board Seat Contact Info
Robert Greif Chief Executive Officer & President
William Horne Chief Executive Officer & Chairman
Charlie Farrahar Chief Financial Officer
You’re viewing 3 of 8 executive team members. Get the full list »

Medovex Board Members (3)

Name Representing Role Since
0000000 0000000000 Medovex Board Member 000 0000
0000000 00000 Medovex Chief Executive Officer & Chairman 000 0000
To view Medovex’s complete board members history, request access »

Medovex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medovex Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medovex‘s full profile, request access.

Request a free trial

Medovex Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 00000 14-Jan-2019 000000000 00000 00 Buildings and Property 0000000 00000
Streamline (Healthcare) 26-Mar-2015 Merger/Acquisition 00.00 Other Healthcare Technology Systems 0000000 000000
To view Medovex’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial